Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ertugliflozin (Steglatro) (1 trial)
anidulafungin (eraxis) (1 trial)
doxorubicin (Doxil) (1 trial)
etelcalcetide (parsabiv) (1 trial)
iron dextran (INFeD) (1 trial)
lapatinib (tykerb) (1 trial)
sodium bicarbonate (1 trial)
tick-borne encephalitis vaccine (TICOVAC) (1 trial)
Breast Neoplasms (Phase 2)
Calcinosis (Phase 2)
Encephalitis (Phase 2)
Encephalitis, Tick-Borne (Phase 2)
Kidney Failure, Chronic (Phase 2)
Neoplasms (Phase 2)
Trials (7 total)
Trial APIs (8 total)